Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH‐mutant and 1p/19q‐codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report. Issue 1 (14th December 2022) - Ehret, Felix; Hansch, Alexander; Meinhardt, Jenny; Hain, Elisabeth Gertrud; Misch, Martin; Onken, Julia; Roohani, Siyer; Koch, Arend; Schweizer, Leonille; Radke, Josefine; Kaul, David